CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis.
Ther Adv Chronic Dis
; 11: 2040622320947378, 2020.
Article
in En
| MEDLINE
| ID: mdl-32913622
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Ther Adv Chronic Dis
Year:
2020
Type:
Article
Affiliation country:
Belgium